Linked Life Data

709512

Source:http://linkedlifedata.com/resource/pubmed/id/709512

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Suppl
pubmed:dateCreated
1979-1-15
pubmed:abstractText
Serial CEA radioimmunoassays have been performed on patients receiving radiation therapy preoperatively or as treatment of recurrent or metastatic colorectal cancer. Pretreatment circulating CEA titers which were elevated showed a significant decrease with accumulating doses of irradiation, indicating that the bulk of CEA-producing tumor was within the radiation therapy portal. The decrease of circulating CEA with preoperative radiation therapy was short-lived and suggested that surgical resection should be performed within 8 weeks of irradiation. Serial CEA titers are useful as an adjunct to other clinical, laboratory and radiologic data in formulating patient management decisions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1434-6
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1978
pubmed:articleTitle
Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancer.
pubmed:publicationType
Journal Article